Follow
Dong Yin
Dong Yin
Unknown affiliation
Verified email at mail.sysu.edu.cn
Title
Cited by
Cited by
Year
Genomic and molecular characterization of esophageal squamous cell carcinoma
DC Lin, JJ Hao, Y Nagata, L Xu, L Shang, X Meng, Y Sato, Y Okuno, ...
Nature genetics 46 (5), 467-473, 2014
6272014
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells
NH Thoennissen, GB Iwanski, NB Doan, R Okamoto, P Lin, S Abbassi, ...
Cancer research 69 (14), 5876-5884, 2009
3082009
Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)
D Yin, H Zhou, T Kumagai, G Liu, JM Ong, KL Black, HP Koeffler
Oncogene 24 (3), 344-354, 2005
2782005
Short-and long-term outcomes after laparoscopic and open hepatectomy for hepatocellular carcinoma: a global systematic review and meta-analysis
Z Yin, X Fan, H Ye, D Yin, J Wang
Annals of surgical oncology 20, 1203-1215, 2013
2662013
Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas
D Xie, D Yin, HJ Wang, GT Liu, R Elashoff, K Black, HP Koeffler
Clinical Cancer Research 10 (6), 2072-2081, 2004
2562004
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (Vorinostat, SAHA) profoundly inhibits the growth of human pancreatic cancer cells
T Kumagai, N Wakimoto, D Yin, S Gery, N Kawamata, N Takai, N Komatsu, ...
International journal of cancer 121 (3), 656-665, 2007
2322007
Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and β-catenin-TCF/Lef signaling pathways
D Xie, D Yin, X Tong, J O’Kelly, A Mori, C Miller, K Black, D Gui, JW Said, ...
Cancer research 64 (6), 1987-1996, 2004
2232004
A role for the clock gene per1 in prostate cancer
Q Cao, S Gery, A Dashti, D Yin, Y Zhou, J Gu, HP Koeffler
Cancer research 69 (19), 7619-7625, 2009
2192009
Genomic and epigenomic heterogeneity of hepatocellular carcinoma
DC Lin, A Mayakonda, HQ Dinh, P Huang, L Lin, X Liu, L Ding, J Wang, ...
Cancer research 77 (9), 2255-2265, 2017
1852017
Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo
D Yin, JM Ong, J Hu, JC Desmond, N Kawamata, BM Konda, KL Black, ...
Clinical Cancer Research 13 (3), 1045-1052, 2007
1832007
Cucurbitacin B has a potent antiproliferative effect on breast cancer cells in vitro and in vivo
N Wakimoto, D Yin, J O’Kelly, T Haritunians, B Karlan, J Said, H Xing, ...
Cancer science 99 (9), 1793-1797, 2008
1562008
Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): simultaneous or delayed?
Z Yin, C Liu, Y Chen, Y Bai, C Shang, R Yin, D Yin, J Wang
Hepatology 57 (6), 2346-2357, 2013
1522013
Connective tissue growth factor is overexpressed in esophageal squamous cell carcinoma and promotes tumorigenicity through β-catenin-T-cell factor/Lef signaling
YZ Deng, PP Chen, Y Wang, D Yin, HP Koeffler, B Li, XJ Tong, D Xie
Journal of Biological Chemistry 282 (50), 36571-36581, 2007
1512007
miR-34a functions as a tumor suppressor modulating EGFR in glioblastoma multiforme
D Yin, S Ogawa, N Kawamata, A Leiter, M Ham, D Li, NB Doan, JW Said, ...
Oncogene 32 (9), 1155-1163, 2013
1462013
SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells
N Komatsu, N Kawamata, S Takeuchi, D Yin, W Chien, CW Miller, ...
Oncology reports 15 (1), 187-191, 2006
1452006
Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells
S Gery, D Xie, D Yin, H Gabra, C Miller, H Wang, D Scott, WS Yi, ...
Clinical cancer research 11 (20), 7243-7254, 2005
1392005
High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray
D Yin, S Ogawa, N Kawamata, P Tunici, G Finocchiaro, M Eoli, C Ruckert, ...
Molecular Cancer Research 7 (5), 665-677, 2009
1292009
Cucurbitacin B markedly inhibits growth and rapidly affects the cytoskeleton in glioblastoma multiforme
D Yin, N Wakimoto, H Xing, D Lu, T Huynh, X Wang, KL Black, HP Koeffler
International Journal of Cancer 123 (6), 1364-1375, 2008
1282008
Dlk1 in normal and abnormal hematopoiesis
S Sakajiri, J O'kelly, D Yin, CW Miller, WK Hofmann, K Oshimi, LY Shih, ...
Leukemia 19 (8), 1404-1410, 2005
1232005
DLK1: increased expression in gliomas and associated with oncogenic activities
D Yin, D Xie, S Sakajiri, CW Miller, H Zhu, ML Popoviciu, JW Said, ...
Oncogene 25 (13), 1852-1861, 2006
1202006
The system can't perform the operation now. Try again later.
Articles 1–20